Drug classifications in nursing: a complete pharmacology reference

Pharmacology is one of the most challenging subjects in nursing school — not because individual drugs are complicated, but because there are thousands of them. The shortcut every experienced nurse learns: you do not memorize drugs one at a time. You memorize drug classes, then individual drugs fall into place.

A drug class groups medications that share the same mechanism of action. Once you understand how a class works, you can predict the therapeutic effects, the side effects, the nursing considerations, and the patient safety alerts for every drug in that class. Lisinopril and captopril are different drugs, but they are both ACE inhibitors — the class tells you everything you need to know for clinical practice and the NCLEX.

This reference covers the 15 major drug classes nursing students encounter in pharmacology and clinical rotations. Each section gives you the mechanism, key examples, primary uses, and the nursing considerations that are most commonly tested and most clinically significant.

Quick reference table

Cardiovascular drugs

ACE inhibitors

Mechanism: Angiotensin-converting enzyme (ACE) inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. The result is vasodilation, reduced blood pressure, and decreased cardiac afterload — making them useful in both hypertension and heart failure.

Key examples: captopril, lisinopril, enalapril

Primary indications: Hypertension, heart failure with reduced ejection fraction (HFrEF), diabetic nephropathy, post-MI cardiac protection

Nursing considerations:

• Dry cough is the most common reason patients stop ACE inhibitors — caused by bradykinin accumulation. This is expected and not dangerous, but worth documenting.
• Angioedema — swelling of the lips, tongue, or airway — is a rare but serious adverse effect. Stop the drug immediately and treat as an emergency.
• Hyperkalemia: ACE inhibitors raise potassium levels. Monitor potassium closely, especially in patients also taking potassium-sparing diuretics or potassium supplements.
• Contraindicated in pregnancy — associated with fetal renal toxicity (especially in 2nd and 3rd trimesters).
• Monitor blood pressure and renal function (BUN, creatinine) when starting or titrating.
• Do not administer if the patient has bilateral renal artery stenosis.

NCLEX tip: If a patient develops a persistent dry cough on an ACE inhibitor, the next step is usually switching to an ARB (angiotensin receptor blocker), which provides similar benefits without the cough.

Beta-blockers

Mechanism: Beta-blockers competitively block beta-adrenergic receptors. Blocking beta-1 receptors (in the heart) slows heart rate and reduces myocardial contractility. Blocking beta-2 receptors (in lungs and blood vessels) causes bronchoconstriction — a key adverse effect.

The “-olol” suffix is your mnemonic. If the drug ends in -olol, it is a beta-blocker: metoprolol, atenolol, carvedilol, propranolol, labetalol.

Primary indications: Hypertension, arrhythmias (especially atrial fibrillation), heart failure (compensated), angina, post-MI, migraine prophylaxis

Nursing considerations:

• Never stop abruptly. Sudden discontinuation can trigger rebound hypertension, angina, or myocardial infarction. Taper the dose when discontinuing.
• Masks hypoglycemia symptoms. Beta-blockers blunt tachycardia — the most reliable early sign of low blood sugar. Diabetic patients must be counseled to watch for other hypoglycemia signs (diaphoresis, altered mental status).
• Contraindicated in asthma and COPD (non-cardioselective beta-blockers). Cardioselective agents (metoprolol, atenolol) carry lower bronchoconstriction risk but should still be used with caution.
• Hold for bradycardia: Hold the dose if heart rate is below 60 bpm (per facility protocol). Document and notify the provider.
• Monitor blood pressure and heart rate before each dose.

Calcium channel blockers

Mechanism: Calcium channel blockers (CCBs) inhibit calcium ion influx into cardiac and smooth muscle cells. Less intracellular calcium means less muscle contraction — resulting in vasodilation and (for non-dihydropyridine CCBs) reduced heart rate and AV node conduction.

There are two subclasses: dihydropyridines (amlodipine, nifedipine) primarily act on vascular smooth muscle; non-dihydropyridines (diltiazem, verapamil) also slow heart rate and are used for arrhythmias.

Key examples: amlodipine, diltiazem, verapamil, nifedipine

Primary indications: Hypertension, chronic stable angina, atrial fibrillation/flutter (rate control), Raynaud’s phenomenon

Nursing considerations:

• Peripheral edema (especially ankle swelling) is a common complaint with dihydropyridines. It is vasodilatory, not fluid retention — diuretics do not help.
• Hypotension and dizziness — assess blood pressure before each dose, especially in elderly patients.
• Constipation is common with verapamil. Counsel patients on dietary fiber, fluids, and stool softeners.
• Diltiazem and verapamil can cause bradycardia and AV block — do not combine with beta-blockers without close cardiac monitoring.
• Grapefruit and grapefruit juice inhibit metabolism of many CCBs (especially amlodipine and nifedipine) — counsel patients to avoid.

Diuretics

Mechanism: Diuretics increase urinary excretion of water and sodium, reducing fluid volume and blood pressure. Each subclass acts at a different part of the nephron.

Primary indications: Hypertension, heart failure, edema, ascites (spironolactone), nephrotic syndrome

Nursing considerations:

• Electrolyte monitoring is mandatory — check BMP (sodium, potassium, chloride, bicarbonate, BUN, creatinine) regularly.
• Loop diuretics at high doses cause ototoxicity — hearing loss or tinnitus, especially with rapid IV infusion of furosemide. Infuse slowly; monitor for hearing complaints.
• Hypokalemia risk with loops and thiazides — monitor for muscle cramps, weakness, and ECG changes (flattened T-waves, U-waves).
• Hyperkalemia risk with potassium-sparing diuretics — avoid potassium supplements concurrently unless closely monitored.
• Spironolactone is an aldosterone antagonist; it is used in HF for its cardioprotective properties in addition to diuresis.
• Assess for dehydration and orthostatic hypotension in patients on aggressive diuretic regimens.

Statins

Mechanism: HMG-CoA reductase inhibitors (statins) block the rate-limiting step in hepatic cholesterol synthesis. Lower hepatic cholesterol production triggers upregulation of LDL receptors, clearing more LDL from the bloodstream.

The “-statin” suffix is your identifier. Atorvastatin, rosuvastatin, simvastatin, pravastatin, lovastatin.

Primary indications: Hyperlipidemia, primary and secondary cardiovascular disease prevention

Nursing considerations:

• Myopathy: Statins can cause muscle pain (myalgia) and, less commonly, severe muscle breakdown. Report unexplained muscle pain or weakness to the provider.
• Rhabdomyolysis is the rare but life-threatening complication — massive muscle breakdown releases myoglobin into the bloodstream, which can cause acute kidney injury. Monitor CK levels if myopathy is suspected. Urine may appear dark (tea-colored).
• Liver function tests (LFTs) should be obtained at baseline and monitored periodically. Statins are hepatically metabolized and can cause transaminase elevation.
• Take most statins in the evening — cholesterol synthesis peaks at night.
• Grapefruit juice interacts with simvastatin and lovastatin (inhibits CYP3A4 metabolism) — counsel patients to avoid it.
• Rosuvastatin and pravastatin are less affected by grapefruit interactions and are preferred in patients on multiple interacting medications.

Anticoagulants

Mechanism: Anticoagulants disrupt the coagulation cascade to prevent clot formation. The mechanism differs by agent: warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X); heparin and low-molecular-weight heparin (LMWH) activate antithrombin III; direct oral anticoagulants (DOACs) directly inhibit specific clotting factors (Factor Xa or thrombin).

Nursing considerations:

• Bleeding is the primary risk — assess for unusual bruising, petechiae, hematuria, black tarry stools, prolonged bleeding from cuts.
• INR monitoring for warfarin is non-negotiable. Narrow therapeutic window; many drug and food interactions. Consistent vitamin K intake (leafy greens) matters — not zero, just consistent.
• Teach bleeding precautions: soft toothbrush, electric razor, avoid contact sports, carry a medical ID.
• Do not give IM injections to anticoagulated patients.
• Hold anticoagulants per protocol before invasive procedures or surgery.
• Subcutaneous injections (heparin, LMWH): inject into abdominal fat, rotate sites, do not aspirate, do not rub the site after injection.

Pain and analgesia

Opioid analgesics

Mechanism: Opioids bind to mu, kappa, and delta opioid receptors in the central and peripheral nervous system, inhibiting pain signal transmission and altering pain perception. They are the most effective agents for moderate-to-severe pain but carry significant risks.

Key examples: morphine, oxycodone, hydromorphone, fentanyl, codeine

Primary indications: Moderate-to-severe acute pain, chronic pain in cancer and palliative care, severe dyspnea (palliative)

Nursing considerations:

• Respiratory depression is the most dangerous adverse effect. Monitor respiratory rate (hold for <12 breaths/min per policy), oxygen saturation, and sedation level. Keep naloxone (Narcan) available.
• Reversal agent: Naloxone (Narcan) — an opioid antagonist that rapidly reverses respiratory depression and sedation. Note that naloxone has a shorter half-life than many opioids; repeat dosing or infusion may be needed.
• Constipation is universal and does not develop tolerance. Every patient on opioids needs a bowel regimen (docusate + stimulant laxative). Do not wait for constipation to develop.
• Nausea and vomiting are common early in therapy — usually improve over days.
• Sedation and dizziness — fall prevention is essential. Side-rails up, call light within reach, ambulate with assistance.
• Equianalgesic dosing: when converting between opioids or routes, use an equianalgesic reference and verify with pharmacy.
• Tolerance and physical dependence develop with long-term use — this is physiologic, not the same as addiction.

NSAIDs

Mechanism: Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit cyclooxygenase enzymes (COX-1 and COX-2), blocking prostaglandin synthesis. Prostaglandins mediate inflammation, pain, and fever — and also protect the gastric mucosa and support renal blood flow. This explains why the therapeutic and adverse effects are tightly linked.

Key examples: ibuprofen, ketorolac, naproxen, aspirin, celecoxib (COX-2 selective)

Primary indications: Mild-to-moderate pain, inflammation, fever, dysmenorrhea; aspirin for antiplatelet/cardiovascular prophylaxis

Nursing considerations:

• GI ulceration and bleeding — NSAIDs inhibit COX-1, which reduces prostaglandin-mediated mucosal protection. Take with food. High-risk patients (elderly, history of ulcer, concurrent corticosteroids) should also take a proton pump inhibitor.
• Renal toxicity — prostaglandins support afferent arteriole dilation in the kidney, especially in states of low perfusion. NSAIDs can precipitate acute kidney injury in patients with CKD, heart failure, cirrhosis, or volume depletion. Avoid NSAIDs in patients with significant renal impairment.
• Cardiovascular risk — selective COX-2 inhibitors (celecoxib) and high-dose traditional NSAIDs are associated with increased risk of MI and stroke with chronic use.
• Platelet aggregation inhibition — NSAIDs impair platelet function (reversibly, except aspirin which is irreversible). Monitor for bleeding, especially peri-operatively.
• Aspirin is contraindicated in children with viral illness (Reye’s syndrome risk).
• Ketorolac (IV/IM NSAID): limit to 5 days maximum; doses above this significantly increase GI and renal toxicity risk.

Anti-infectives

Antibiotics by class

Antibiotics are grouped by their mechanism of action and spectrum of coverage. Understanding the class predicts the toxicity profile and key nursing alerts.

Nursing considerations across all antibiotic classes:

• C. diff risk: Broad-spectrum antibiotics disrupt normal gut flora and can trigger Clostridioides difficile colitis. Report diarrhea (especially ≥3 loose stools per day) and assess for fever and abdominal pain. C. diff requires contact precautions and soap-and-water hand hygiene (alcohol-based gel is insufficient).
• Culture before antibiotics when possible — blood, urine, wound, or sputum cultures should be collected before the first antibiotic dose when clinically feasible. This allows de-escalation to a narrower agent once sensitivities return.
• Assess for allergies before every antibiotic course. A penicillin allergy documented in the chart requires extra caution with cephalosporins — confirm the nature of the reaction (rash vs. anaphylaxis) and consult pharmacy.
• Aminoglycoside monitoring: Check peak and trough levels. Toxicity is dose- and duration-dependent. Avoid concurrent nephrotoxins (NSAIDs, contrast, vancomycin if possible).
• Vancomycin infusion: Infuse over at least 60 minutes. Faster infusion causes red man syndrome — facial flushing, erythema, and pruritus from histamine release. Treat by slowing the rate; this is not a true allergic reaction.
• Teach patients to complete the full antibiotic course even if symptoms resolve, to prevent resistance.

Endocrine and metabolic

Corticosteroids

Mechanism: Synthetic corticosteroids (glucocorticoids) mimic endogenous cortisol, suppressing immune and inflammatory responses by inhibiting cytokine production and stabilizing cell membranes. At higher doses, they also suppress the hypothalamic-pituitary-adrenal (HPA) axis.

Key examples: prednisone, methylprednisolone (Solu-Medrol), dexamethasone, hydrocortisone

Primary indications: Inflammation and autoimmune conditions, asthma exacerbations, allergic reactions, adrenal insufficiency, cerebral edema, anti-emesis in chemotherapy, organ transplant immunosuppression

Nursing considerations:

• Never stop abruptly. Prolonged corticosteroid use suppresses the HPA axis. Abrupt discontinuation can trigger adrenal crisis (severe hypotension, weakness, cardiovascular collapse). Taper the dose under provider guidance.
• Cushingoid effects with long-term use: moon face, buffalo hump, central obesity, skin thinning, easy bruising, acne, hirsutism.
• Hyperglycemia — corticosteroids cause insulin resistance and stimulate gluconeogenesis. Monitor blood glucose in all patients, especially diabetics and those receiving high doses.
• Infection susceptibility — immunosuppression increases infection risk. Monitor for signs of infection; fever may be blunted.
• GI ulceration — especially when combined with NSAIDs. Take with food; a PPI may be prescribed concurrently.
• Osteoporosis with long-term use — calcium and vitamin D supplementation are commonly prescribed; bone density monitoring recommended.
• Mood changes and insomnia — patients may experience euphoria, irritability, or psychosis, especially at high doses.
• Corticosteroid doses are often prescribed in a taper schedule — educate patients on the importance of following the schedule exactly.

Antidiabetics

Mechanism: Antidiabetic medications lower blood glucose through different mechanisms depending on the class. Insulin replaces endogenous hormone entirely. Oral and injectable agents either stimulate insulin secretion, improve insulin sensitivity, slow carbohydrate absorption, or increase glucose excretion.

Nursing considerations:

• Hypoglycemia is the primary safety concern for insulin and sulfonylureas. Know the facility’s hypoglycemia protocol: blood glucose <70 mg/dL (or per protocol) requires treatment with 15 g fast-acting carbohydrate (15-15 rule). Severe hypoglycemia may require IV dextrose or glucagon.
• Metformin and lactic acidosis: Hold metformin before IV contrast administration and in patients with acute illness, significant dehydration, or GFR <30 mL/min — risk of lactic acidosis.
• Insulin storage and handling: Unopened vials/pens are stored in the refrigerator. Once opened, most can be stored at room temperature for 28–30 days (check the specific product). Never freeze insulin.
• Insulin administration technique: Rotate injection sites within the same region to prevent lipodystrophy (fatty lump formation from repeated injections in the same spot). Lipodystrophy causes erratic insulin absorption.
• DKA vs. HHS: Diabetic ketoacidosis (DKA) occurs primarily in Type 1 diabetes — marked by hyperglycemia, ketonemia, and metabolic acidosis. Hyperosmolar hyperglycemic state (HHS) occurs in Type 2 — severe hyperglycemia without significant ketosis, with extreme dehydration. Both are emergencies.
• Monitor blood glucose per protocol; document and report values outside the target range.

Thyroid medications

Mechanism: Thyroid medications either replace deficient thyroid hormone (hypothyroidism) or suppress excessive thyroid hormone production (hyperthyroidism).

For hypothyroidism: Levothyroxine (LT4) is synthetic T4, the prodrug form of thyroid hormone. It is converted to active T3 in peripheral tissues.

For hyperthyroidism: Propylthiouracil (PTU) and methimazole block thyroid hormone synthesis. PTU also blocks peripheral conversion of T4 to T3 — making it preferred in thyroid storm and first trimester pregnancy.

Key examples: levothyroxine (Synthroid), propylthiouracil (PTU), methimazole

Nursing considerations — levothyroxine:

• Narrow therapeutic window. Monitor TSH levels; dose adjustments are made in small increments. Overtreatment causes cardiac arrhythmias, bone density loss, and anxiety.
• Take on an empty stomach, 30–60 minutes before breakfast, for consistent absorption. Many drugs and supplements reduce absorption (calcium, iron, antacids — separate by at least 4 hours).
• Signs of over-replacement (thyrotoxicosis): tachycardia, palpitations, heat intolerance, weight loss, tremor, diarrhea, insomnia.
• Long-term excess increases risk of atrial fibrillation and osteoporosis.

Nursing considerations — PTU/methimazole:

• Agranulocytosis is a rare but life-threatening adverse effect — sudden onset fever, sore throat, or malaise in a patient on antithyroid drugs requires immediate CBC and drug hold pending results.
• Monitor for hypothyroidism developing during treatment — TSH and free T4 levels guide dosing.

CNS drugs

Benzodiazepines

Mechanism: Benzodiazepines enhance the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors, the main inhibitory neurotransmitter in the CNS. The result is anxiolysis, sedation, muscle relaxation, and anticonvulsant activity.

Key examples: lorazepam (Ativan), diazepam (Valium), midazolam (Versed), alprazolam, clonazepam

Primary indications: Anxiety disorders, acute seizures and status epilepticus, alcohol withdrawal (CIWA protocol), procedural sedation (midazolam), muscle spasm

Nursing considerations:

• Respiratory depression is the major risk — especially dangerous when combined with opioids, other CNS depressants, or alcohol. The combination of benzodiazepines and opioids significantly multiplies overdose risk.
• Reversal agent: Flumazenil — a competitive benzodiazepine antagonist. Use with caution: it can precipitate acute withdrawal seizures in benzodiazepine-dependent patients, and it has a shorter half-life than most benzodiazepines (resedation can occur).
• Fall risk: Sedation and muscle relaxation impair balance and coordination. Institute fall precautions: side rails, call light, assist with ambulation.
• Dependence and withdrawal: Physical dependence develops with regular use. Abrupt discontinuation can cause rebound anxiety, tremors, insomnia, and seizures. Taper dose when discontinuing.
• Monitor level of sedation using a validated scale (Richmond Agitation-Sedation Scale — RASS) in clinical settings.
• Lorazepam is preferred in hepatic impairment (does not require hepatic oxidation — conjugation only).

Antipsychotics

Mechanism: Antipsychotics primarily block dopamine D2 receptors in the mesolimbic pathway, reducing positive symptoms of psychosis (hallucinations, delusions). First-generation (typical) antipsychotics have higher D2 affinity and greater extrapyramidal side effect risk. Second-generation (atypical) antipsychotics also block serotonin receptors, offering broader symptom coverage with a different side effect profile.

Key examples:

• Typical: haloperidol (Haldol), chlorpromazine
• Atypical: quetiapine (Seroquel), risperidone, olanzapine, aripiprazole, clozapine

Primary indications: Schizophrenia, bipolar disorder (acute mania and maintenance), adjunctive use in severe depression, delirium (haloperidol)

Nursing considerations:

• Extrapyramidal symptoms (EPS) are the hallmark adverse effects of typical antipsychotics: akathisia (inner restlessness, inability to sit still), dystonia (acute muscle spasm/rigidity), parkinsonism (tremor, bradykinesia, shuffling gait), and tardive dyskinesia (repetitive involuntary movements — often irreversible).
• Tardive dyskinesia (TD) develops with long-term use — tongue thrusting, lip smacking, facial grimacing. Assess with AIMS (Abnormal Involuntary Movement Scale) at each visit. Report new movements to the provider.
• QT prolongation — antipsychotics (especially haloperidol IV, thioridazine, ziprasidone) prolong the QT interval and can cause torsades de pointes. Obtain baseline ECG and monitor electrolytes (hypokalemia and hypomagnesemia worsen QT prolongation risk).
• Metabolic effects (atypical antipsychotics, especially olanzapine and clozapine): weight gain, hyperglycemia, hyperlipidemia — monitor metabolic panel and waist circumference.
• Neuroleptic malignant syndrome (NMS) is a rare but life-threatening emergency: hyperthermia, muscle rigidity, altered consciousness, autonomic instability. Stop the antipsychotic immediately and treat as an emergency.
• Clozapine carries a unique risk of agranulocytosis — mandatory WBC and ANC monitoring every 1–4 weeks per protocol.

GI drugs

Proton pump inhibitors

Mechanism: Proton pump inhibitors (PPIs) irreversibly inhibit the H+/K+ ATPase enzyme (the “proton pump”) on the surface of gastric parietal cells, blocking the final step of acid secretion. This reduces gastric acid production by up to 90%.

The “-prazole” suffix identifies this class. Omeprazole (Prilosec), pantoprazole (Protonix), lansoprazole (Prevacid), esomeprazole, rabeprazole.

Primary indications: GERD, peptic ulcer disease, H. pylori eradication (in combination), Zollinger-Ellison syndrome, stress ulcer prophylaxis in critically ill patients, GI protection in patients on NSAIDs or corticosteroids

Nursing considerations:

• Long-term use depletes magnesium. Hypomagnesemia from chronic PPI use can present as muscle cramps, tremors, seizures, and cardiac arrhythmias. Monitor magnesium in patients on long-term PPIs.
• C. diff risk increases with PPI use — suppressing gastric acid removes one of the body’s natural defenses against Clostridioides difficile. Combined with antibiotics, the risk is further elevated.
• Bone density: Long-term PPI use is associated with reduced absorption of calcium and an increased risk of osteoporosis-related fractures, particularly hip fractures.
• Administer 30–60 minutes before a meal — PPIs require parietal cells to be actively secreting acid for maximum effect. Taking them with or after a meal reduces efficacy.
• Assess for ongoing indication — PPIs are frequently continued indefinitely without reassessment. NCLEX and clinical practice both expect nurses to question appropriateness of long-term PPI use.
• Pantoprazole is the preferred IV form in hospitalized patients due to fewer drug interactions than IV omeprazole.

How to use this in nursing school

Learn the class before individual drugs

The most efficient approach to pharmacology is class-first learning. Instead of memorizing that metoprolol causes bradycardia and atenolol causes bradycardia and carvedilol causes bradycardia as three separate facts, you learn one rule: beta-blockers slow the heart.

Apply the same logic to suffixes:

• -olol = beta-blocker → bradycardia, don’t stop abruptly
• -pril = ACE inhibitor → dry cough, hyperkalemia, angioedema
• -statin = HMG-CoA reductase inhibitor → myopathy, LFT monitoring
• -prazole = proton pump inhibitor → magnesium depletion long-term
• -xaban or -gatran = DOAC anticoagulant → bleeding, no routine INR monitoring

Use class patterns to predict NCLEX answers

NCLEX pharmacology questions rarely test whether you know a specific drug name. They test whether you know the class behavior:

• A patient is prescribed metoprolol. What should the nurse check before administering? → Heart rate (beta-blocker reflex)
• A patient on warfarin reports eating more leafy greens. What is the priority? → INR check (vitamin K interacts with warfarin)
• Which assessment finding requires the nurse to hold the ordered dose of furosemide? → Potassium below 3.5 mEq/L (loop diuretic depletes potassium)

Prioritize the reversal agents

For NCLEX and clinical safety, know these cold:

Practice with the NCLEX practice quiz

The pharmacology category in the quiz includes questions on the drug classes covered here, with full rationales explaining why each answer is correct and why the distractors are wrong.

Related resources

• Medication rights in nursing — the 5, 6, 7, and 10 rights framework for safe drug administration
• Nursing lab values cheat sheet — CBC, BMP, CMP, ABG, and coagulation studies — essential for monitoring drug effects
• Drug dosage calculator — weight-based dosing, IV drip rate, flow rate, and unit conversions
• Electrolyte imbalances nursing guide — critical for monitoring diuretic and corticosteroid therapy

This reference is for educational purposes. Clinical decisions should always be made in conjunction with facility protocols, current prescribing information, and senior clinical staff.